FDA Grants Approval to HPBCD-Enhanced Biologic: A ‘Super-Originator’ Formulation
Cyclodextrin-based super-generics represent enhanced versions of reformulated drug products, offering improved performance and patient outcomes usually developed/marketed by a generic
